Skip to content
Echo ReferenceLV Diastolic Function
Echo Reference — Diastolic Function & Haemodynamics

LV Diastolic Function Grading: 2025 ASE Algorithm

Thresholds, algorithms and interpretation from the 2025 ASE update — diagnosis of diastolic dysfunction, left atrial pressure estimation, dedicated pathways for AF, MAC, pulmonary hypertension and transplant recipients, measurement pitfalls and reporting.

Reviewed by Dr Reza Moazzeni, MD FRACP · Consultant Cardiologist
Last medically reviewed: August 2026

The interactive tool below applies the correct 2025 ASE pathway once you select the clinical context. The full reference — diagnostic criteria, threshold tables, phenotype algorithms, pitfalls and reporting guidance — follows underneath.

Interactive Diastolic Function Grading Tool

Select the clinical context and enter measurements step by step. The tool applies the correct 2025 ASE algorithm and shows the variables that drove the result. Use the Back button to revise any step.

Scope: This tool implements the resting algorithms only. It does not apply to mitral stenosis, moderate–severe mitral regurgitation, LVAD, pericardial constriction, or patients after mitral valve repair, replacement or edge-to-edge repair — see the corresponding sections below. Results support, but do not replace, integrated clinical interpretation.

Two Separate Questions: Is Diastolic Dysfunction Present, and Is LAP Elevated?

The 2025 ASE update separates two questions that are frequently conflated. The first — is LV diastolic dysfunction present? — follows Figure 2 and uses age-specific e′ cut-offs. The second — is mean left atrial pressure elevated, and what grade? — follows Figure 3 and uses age-independent e′ cut-offs. Applying the wrong set of cut-offs to the wrong question is the most common source of error in diastolic reporting.

Step 1 — Assess LV Relaxation (Age-Specific Cut-offs)

These are diagnostic cut-offs for impaired relaxation, not population reference ranges. An e′ below the value for the patient's age group counts as reduced.

Swipe table to see all columns →
Age Abnormal septal e′ Abnormal lateral e′ Abnormal average e′
20 – 39 years< 7 cm/s< 10 cm/s< 9 cm/s
40 – 65 years< 6 cm/s< 8 cm/s< 7 cm/s
> 65 years< 6 cm/s< 7 cm/s< 6.5 cm/s

Step 2 — Markers of Elevated LAP and Structural Remodelling

Parameter Abnormal Role
Average E/e′> 14Elevated LAP marker
LA reservoir strain (LARS)≤ 18%Elevated LAP marker
E/A ratio (high)≥ 2Elevated LAP marker
E/A ratio (low)≤ 0.8Impaired relaxation — not elevated LAP
LA volume index (biplane)> 34 mL/m²Structural surrogate
LV mass index — men> 115 g/m²Structural surrogate
LV mass index — women> 95 g/m²Structural surrogate
Diagnostic logic: If e′ is reduced for age, only one Step 2 criterion is required to diagnose diastolic dysfunction. If e′ is preserved, two Step 2 criteria are required. Note that E/A ≤ 0.8 supports impaired relaxation but does not indicate elevated LAP — elevated LAP is supported by E/A ≥ 2, average E/e′ > 14, LARS ≤ 18% and raised TR velocity or PASP.

Primary Variables — Sinus Rhythm LAP Algorithm

Three primary variables are assessed simultaneously. These cut-offs are age-independent and belong to the filling-pressure algorithm, not the diagnostic step above. For LA size and strain reference values, see left atrial size and function.

Variable Abnormal threshold
1. Reduced e′ velocitySeptal e′ ≤ 6 cm/s, lateral e′ ≤ 7 cm/s, or average e′ ≤ 6.5 cm/s
2. Increased E/e′ ratioSeptal E/e′ ≥ 15, lateral E/e′ ≥ 13, or average E/e′ ≥ 14
3. Increased TR velocity / PASPTR velocity ≥ 2.8 m/s or PASP ≥ 35 mmHg

Supplementary Criteria

Primary supplementary Threshold
Pulmonary vein S/D ratio≤ 0.67
LA reservoir strain (LARS)≤ 18%
LA volume index (LAVi)> 34 mL/m²
IVRT≤ 70 ms
Pulmonary vein S/D: Most reliable when LV systolic function is impaired. S/D may be ≤ 0.67 in otherwise normal individuals, and may remain > 0.67 despite raised filling pressure when EF is normal. LARS: values of 18–24% represent a low-normal zone with higher sensitivity but lower specificity than ≤ 18%.
Additional supplementary methods Threshold
PR end-diastolic velocity≥ 2 m/s
PA diastolic pressure≥ 16 mmHg
Mitral inflow L-wave velocity≥ 50 cm/s
Ar–A duration> 30 ms
Decrease in mitral E/A with Valsalva≥ 50%
Do not apply the sinus rhythm algorithm in: moderate–severe mitral annular calcification, moderate–severe mitral regurgitation, mitral stenosis, atrial fibrillation, LVAD, non-cardiac pulmonary hypertension, heart transplant recipients, pericardial constriction, or after mitral valve repair, replacement or transcatheter edge-to-edge repair. Each has a dedicated pathway below, and the interactive tool routes to it automatically.

Diastolic Dysfunction Grades

Swipe table to see all columns →
Grade Filling pattern E/A Mean LAP Interpretation
Normal Normal relaxation E > A (young), E ≈ A (older) Normal Normal diastolic function with no elevation of filling pressures.
Grade 1 Impaired relaxation ≤ 0.8 Normal Impaired relaxation with normal estimated mean LAP at rest. LVEDP may still be elevated. In symptomatic patients, a normal resting pressure does not exclude exercise-induced elevation — consider diastolic exercise echocardiography.
Grade 2 Pseudonormal 0.8 – 2.0 Elevated (mild–moderate) Inflow appears normal but filling pressures are elevated. Supplementary variables are needed to unmask it. A Valsalva-induced fall in E/A of ≥ 50% distinguishes Grade 2 from Grade 1.
Grade 3 Restrictive ≥ 2.0 Elevated (marked) Markedly elevated filling pressures with a stiff, non-compliant ventricle, short deceleration time and adverse prognosis.
Grade 3a versus 3b: If the restrictive pattern reverses to a pseudonormal or impaired-relaxation pattern with Valsalva (E/A fall ≥ 50%), it is Grade 3a (reversible). If it persists, it is Grade 3b (fixed), which carries a worse prognosis. Indeterminate is a valid result — when the data conflict, report indeterminate rather than forcing a grade, and state the filling-pressure conclusion separately.

When Resting Echo Is Not Enough

A normal resting study does not exclude exercise-induced elevation of filling pressure. Diastolic stress echocardiography should be considered in four situations:

Situation Why
Exertional dyspnoea with Grade 1 dysfunctionResting LAP is normal by definition in Grade 1, so the resting study cannot address the symptom
Indeterminate resting LAPExercise frequently resolves the ambiguity
High clinical suspicion of HFpEF despite a normal resting studyFilling pressure may only rise with tachycardia and increased venous return
Isolated elevation of LVEDPPredisposes to elevated mean LAP with exercise or tachycardia
A positive diastolic stress study requires an elevated average E/e′ (≥ 14) or septal E/e′ (≥ 15) together with an elevated peak TR velocity. E/e′ alone is insufficient, because it rises with exercise in normal subjects. Where non-invasive assessment remains inconclusive and the diagnosis would change management, invasive exercise haemodynamics is the reference standard.

Phenotype-Based Approach — When to Deviate from the Standard Algorithm

The standard diastolic variables break down when the underlying physiology is altered — absent atrial contraction, a rigid annulus, surgically modified chambers, or right ventricular pressure loading. The guideline assigns dedicated algorithms to each phenotype, selecting the variables that remain physiologically valid. The core principle: identify which component of the assessment is unreliable, then shift to the parameter that still works.

Swipe table to see all columns →
Phenotype What breaks Most reliable parameters Unreliable / avoid
Sinus rhythm Nothing — normal physiology e′, E/e′, E/A, LAVi, LA strain
Atrial fibrillation No atrial contraction; irregular RR intervals E velocity and E/e′ averaged over ≥ 5 beats, TR velocity, DT E/A ratio; single-beat measures; LARS as a standalone marker; PV Ar velocity (absent)
Moderate–severe MAC Rigid annulus lowers e′ while a reduced orifice raises E E/A, then IVRT when intermediate e′ and E/e′ — artificially elevated
Heart transplant Denervation, small stiff surgical LA, altered filling physiology Average E/e′ with strict cut-offs, E/SRIVR, TR velocity E/A pattern; PV S/D ratio
Pulmonary hypertension RV pressure loading and septal displacement E/A with E velocity qualifier, then LARS or lateral E/e′ Septal e′ and average E/e′; TR velocity as a primary variable
LBBB / RV pacing Septal dyssynchrony reduces septal e′ Lateral E/e′, TR velocity, LA volume and strain Septal and average E/e′

Atrial Fibrillation

Average all measurements over at least five cycles, selecting beats that reflect the average heart rate. No single parameter is sufficient.

Primary variableAbnormal
Mitral E velocity≥ 100 cm/s
Septal E/e′> 11
TR velocity / PASP> 2.8 m/s or > 35 mmHg
Deceleration time≤ 160 ms
≥ 3 abnormal → elevated LAP · ≤ 1 abnormal → normal LAP · 2 abnormal → apply secondary criteria
Secondary criteria (when exactly 2 primary are abnormal)LARS < 18%, PV S/D < 1, BMI > 30 kg/m² — ≥ 2 present → elevated LAP; none → normal LAP; 1 or unavailable → indeterminate

Moderate–Severe Mitral Annular Calcification

This pathway applies specifically to moderate or severe MAC, not to mitral valve disease generally. Significant MAC reduces the effective mitral orifice, raising transmitral velocities, while restricting annular excursion and lowering lateral e′ — inflating E/e′ from both directions.

FindingConclusion
E/A < 0.8Normal LAP
E/A > 1.8Elevated LAP
E/A 0.8 – 1.8, IVRT < 80 msElevated LAP
E/A 0.8 – 1.8, IVRT ≥ 80 msNormal LAP

Mitral Stenosis and Mitral Regurgitation

Mitral stenosis and mitral regurgitation have their own indicators and should not be assessed with the MAC pathway.

LesionIndicators of elevated LAP
Mitral stenosisIVRT < 60 ms; mitral A peak velocity > 1.5 m/s; IVRT/TE-e′ < 4.2
Mitral regurgitationIVRT < 60 ms; Ar–A duration ≥ 30 ms; IVRT/TE-e′ < 5.6
E/e′ in mitral regurgitation: Not useful in primary MR with normal EF, where increased LA and LV compliance attenuates the rise in LAP. E/e′ does correlate with filling pressure in secondary MR with depressed EF. Ar–A duration ≥ 30 ms remains a reliable indicator of elevated LVEDP irrespective of MR severity, since MR does not affect the pulmonary vein Ar velocity. LARS has no consistent relationship with LA pressure in significant MR.

Heart Transplant Recipients

FindingConclusion
Average E/e′ < 7Normal LAP
Average E/e′ > 14Elevated LAP
Average E/e′ 7 – 14, E/SRIVR ≤ 200 cmNormal LAP
Average E/e′ 7 – 14, E/SRIVR > 200 cmElevated LAP
E/SRIVR unavailableTR velocity ≤ 2.8 m/s → normal; > 2.8 m/s → elevated
Transplant filling patterns: A predominant early-filling or restrictive-like mitral inflow pattern is common after transplantation, particularly in the early postoperative period, and may occur despite normal resting filling pressures. It should not be interpreted in isolation. Denervation-related sinus tachycardia frequently causes E/A fusion, and the PV S/D ratio is unreliable in young donor hearts. No single diastolic parameter reliably predicts graft rejection.

Pulmonary Hypertension

The aim here is to determine whether the echocardiographic pattern favours pre-capillary or post-capillary physiology. Right heart catheterisation remains definitive when haemodynamic classification is clinically required. Use lateral E/e′ rather than average, because elevated RV pressures displace the septum and make septal e′ unreliable.

FindingFavours
E/A ≤ 0.8 with E ≤ 50 cm/sPre-capillary PH, normal LAP
E/A ≥ 2 with reduced e′Post-capillary (group 2) PH, elevated LAP
E/A 0.8 – 2, or E/A ≤ 0.8 with E > 50 cm/s → LARS > 18%Normal LAP
Same intermediate group → LARS ≤ 18%Elevated LAP
LARS unavailable → lateral E/e′ < 8 / > 13 / 8–13Normal / elevated / indeterminate

Indicators of Elevated LV Filling Pressure in Other Populations

Swipe table to see all columns →
Population Key indicators of elevated LV filling pressure
Sinus tachycardiaPredominant early filling with depressed EF; IVRT ≤ 70 ms; average E/e′ > 14. When E and A are fused, the compensatory pause after a premature beat may separate the waves.
Hypertrophic cardiomyopathyAverage E/e′ > 14; Ar–A ≥ 30 ms; peak TR velocity > 2.8 m/s; LA maximum volume index > 34 mL/m².
Restrictive cardiomyopathyAverage E/e′ > 14; DT < 140 ms; E/A > 2.5; IVRT < 50 ms; septal and lateral e′ 3–4 cm/s. These are specific but not sensitive.
Mitral stenosisIVRT < 60 ms; mitral A peak velocity > 1.5 m/s; IVRT/TE-e′ < 4.2.
Mitral regurgitationIVRT < 60 ms; Ar–A ≥ 30 ms; IVRT/TE-e′ < 5.6; average E/e′ > 14 when EF is depressed.
LV assist deviceE/A > 2; RAP > 10 mmHg; PASP > 40 mmHg; average E/e′ > 14 or septal E/e′ ≥ 15; LAVi > 33 mL/m²; interatrial septum position.
Cardiac amyloidosis red flags in a restrictive phenotype: increased LV and RV wall thickness, biatrial enlargement, preserved EF with low stroke volume index, the "5-5-5 sign" (s′, e′ and a′ all < 5 cm/s), and apical sparing on longitudinal strain. See unexplained LV hypertrophy and GLS reference values.

Measurement Pitfalls

Swipe table to see all columns →
Measurement Pitfall Impact
Mitral e′ (TDI)Sample volume not at the annulusDistorts e′. Place at or within 1 cm of the annular insertion.
Mitral e′ (TDI)Annular calcification distorting tissue motione′ unreliable in moderate–severe MAC. Use the MAC pathway.
Mitral E velocitySample volume not at the leaflet tipsE is maximal at the tips; placement further into the LV underestimates it.
Mitral E/AE–A fusion with tachycardiaE/A uninterpretable when fused. Where E at the onset of A exceeds 20 cm/s, A is artefactually elevated and may mimic impaired relaxation. Use a compensatory pause, or DT and TDI instead.
Mitral E velocitySignificant MR increasing transmitral flowE is raised by volume overload, not LAP alone — E/A and E/e′ may overstate severity.
TR velocityIncomplete envelope or non-parallel alignmentUnderestimates PASP. Use multiple windows; an ultrasound-enhancing agent may improve the signal.
TR velocityElevated TR in non-cardiac PHReflects pulmonary pressure, not LAP. Use the PH pathway, which avoids TR as a primary variable.
E/e′ ratioSeptal e′ with septal wall motion abnormality, LBBB or RV pacingSeptal e′ unreliable. Use lateral E/e′.
LA volumeForeshortened views or wrong phaseLAVi is measured at end-systole, just before mitral valve opening. Foreshortening underestimates it.
All DopplerNot averaging across cyclesAverage ≥ 3 cycles in sinus rhythm and ≥ 5 in atrial fibrillation.

Constriction versus Restriction

Both present with diastolic heart failure, elevated filling pressures and preserved EF. The distinction matters because constriction is surgically treatable. The 2025 guideline's Figure 7 approach begins with mitral E/A > 0.8 and a dilated IVC, then assesses respirophasic septal motion and medial e′.

Swipe table to see all columns →
Parameter Constriction Restriction
Respirophasic septal shift / septal bouncePresent — characteristicAbsent
Medial annular e′> 7 cm/s (annulus paradoxus); > 8 cm/s favours constriction< 5 cm/s; < 6 cm/s favours restriction
Medial versus lateral e′Medial ≥ lateral (annulus reversus)Lateral > medial (normal pattern)
Mitral inflow respiratory variation> 25% (tricuspid > 40%)Typically minimal
Hepatic vein flowExpiratory diastolic reversal / forward ratio ≥ 0.8Systolic or inspiratory reversal
Longitudinal strainRelatively preserved GLS; strain reversus (lateral < septal)Reduced GLS; apical sparing in amyloidosis
Wall thicknessNormalMay be increased — amyloid, Fabry, haemochromatosis
PericardiumMay be thickened, but thickness is not required for the diagnosisNormal; small effusion possible in amyloid
Diagnostic performance: In the guideline's stepwise approach, respirophasic septal motion combined with medial e′ gives approximately 80% sensitivity and 96% specificity when both are positive. A normal or increased medial annular e′ in a patient with heart failure should raise suspicion for constriction. Mixed constrictive–restrictive physiology occurs, particularly after mediastinal radiation. Constrictive pericarditis can be present with a pericardium of normal thickness, so normal thickness never excludes it — CMR is the next step when echo is equivocal, and simultaneous LV/RV pressure recording remains definitive.

Reporting Checklist

The guideline recommends that reports state both the diastolic function grade and the filling-pressure conclusion wherever possible. Where a grade cannot be assigned, the filling-pressure status should still be reported.

ReportDetail
ContextRhythm, heart rate and blood pressure at the time of the study
GradeNormal, Grade 1, Grade 2, Grade 3, or indeterminate
Mean LAPNormal, elevated, or indeterminate — stated separately from the grade
Always includeMitral inflow velocities, mitral annular e′, E/A, average E/e′, peak TR velocity
Include if relied uponLARS, PV S/D ratio, mitral A duration, PV Ar duration, IVRT
Algorithm usedState when a special-population pathway was applied instead of the sinus rhythm algorithm
ComparisonNote any change from the previous study
Further assessmentRecommend diastolic exercise echocardiography where clinically appropriate
Isolated elevation of LVEDP should be reported even when mean LAP is normal — it predisposes to elevated filling pressure with exercise or tachycardia.

What Changed in 2025

ChangePractical effect
Diagnosis separated from LAP estimationAge-specific e′ cut-offs for diagnosing dysfunction; age-independent cut-offs within the LAP algorithm
Revised three-variable resting algorithme′, E/e′ and TR/PASP assessed simultaneously rather than sequentially
LA reservoir strain incorporatedLARS ≤ 18% now a primary supplementary criterion and a discriminator in AF and PH
Dedicated phenotype pathwaysDistinct algorithms for AF, moderate–severe MAC, pulmonary hypertension and transplantation
Closer integration with HFpEFExplicit role for diastolic exercise echocardiography in symptomatic patients with normal or indeterminate resting findings
Reporting requirements strengthenedGrade and filling pressure both reported; indeterminate is an acceptable conclusion

Frequently Asked Questions

Which e′ cut-offs should I use — age-specific or fixed?

Both, for different purposes. Use the age-specific cut-offs (septal < 7 / < 6 / < 6 cm/s for ages 20–39, 40–65 and over 65) when answering whether diastolic dysfunction is present. Use the age-independent cut-offs (septal ≤ 6, lateral ≤ 7, average ≤ 6.5 cm/s) within the filling-pressure algorithm. Applying the age-specific values inside the LAP algorithm, or the fixed values to the diagnostic step, is a common error.

How do you estimate left atrial pressure in atrial fibrillation?

Average measurements over at least five cycles and assess four variables: mitral E ≥ 100 cm/s, septal E/e′ > 11, TR velocity > 2.8 m/s or PASP > 35 mmHg, and deceleration time ≤ 160 ms. Three or more abnormal indicates elevated LAP; none or one indicates normal LAP. With exactly two abnormal, apply the secondary criteria — LARS < 18%, pulmonary vein S/D < 1 and BMI > 30 kg/m². The E/A ratio cannot be used, and LARS should not be used as a standalone marker.

When should diastolic stress echocardiography be performed?

Consider it in symptomatic patients with Grade 1 diastolic dysfunction, indeterminate resting filling pressure, or a high clinical suspicion of HFpEF despite an apparently normal resting study. A positive result requires an elevated average E/e′ (≥ 14) or septal E/e′ (≥ 15) together with an elevated peak TR velocity, since E/e′ rises with exercise in normal subjects as well.

How do you distinguish constrictive pericarditis from restrictive cardiomyopathy?

The two most useful findings are respirophasic ventricular septal shift and the medial annular e′ velocity. Medial e′ above 7 cm/s despite heart failure — annulus paradoxus — favours constriction, while values below 5 cm/s favour restriction. Combined, these two steps give roughly 80% sensitivity and 96% specificity. Supporting features for constriction include annulus reversus, mitral inflow respiratory variation above 25%, and expiratory hepatic vein diastolic flow reversal. Normal pericardial thickness does not exclude constriction.

References
  1. Nagueh SF, Sanborn DY, Oh JK, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(7):537–569. doi:10.1016/j.echo.2025.03.011
  2. Lang RM, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.
  3. Welch TD, et al. Echocardiographic Diagnosis of Constrictive Pericarditis: Mayo Clinic Criteria. Circ Cardiovasc Imaging. 2014;7(3):526–534.
  4. Klein AL, et al. American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease. J Am Soc Echocardiogr. 2013;26(9):965–1012.
Methodology: Thresholds on this page are transcribed from the cited guidelines and cross-checked against the published tables and figures. Where a parameter is method-dependent or vendor-dependent, this is stated in the relevant section. This page is a clinical reference for practitioners and does not replace individual clinical judgement.